Hjem › Adenokarcinom i spiserøret
Kliniske studier for Adenokarcinom i spiserøret rekrutterer i USA
47 studier for Adenokarcinom i spiserøret rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- New York City, NY18 studier
- Boston, MA13 studier
- Houston, TX12 studier
- Nashville, TN11 studier
- Arlington, VA11 studier
- Durham, NC10 studier
- Los Angeles, CA9 studier
- St. Louis, MO9 studier
- Queens, NY9 studier
- Baldwin Park, CA9 studier
- Rochester, MN9 studier
- Jacksonville, FL9 studier
- Chicago, IL8 studier
- Pittsburgh, PA8 studier
- Philadelphia, PA8 studier
- Dallas, TX8 studier
- Orange, CA7 studier
- Seattle, WA7 studier
- Ann Arbor, MI7 studier
- Evanston, IL6 studier
- Indianapolis, IN6 studier
- Washington, DC6 studier
- Minneapolis, MN6 studier
- Portland, OR6 studier
- Aurora, CO6 studier
- Cleveland, OH6 studier
- New Haven, CT5 studier
- Sioux Falls, SD5 studier
- Greenburgh, NY5 studier
- Kansas City, MO5 studier
- Rochester, NY5 studier
- Charleston, SC5 studier
- San Antonio, TX5 studier
- Denver, CO5 studier
- Tampa, FL4 studier
- Cedar Rapids, IA4 studier
- Salt Lake City, UT4 studier
- Waukegan, IL4 studier
- Bridgeport, CT4 studier
- San Francisco, CA4 studier
Etter delstat
- Alaska3 studier
- Arizona10 studier
- Arkansas4 studier
- California22 studier
- Colorado11 studier
- Connecticut7 studier
- Delaware3 studier
- District of Columbia4 studier
- Florida15 studier
- Georgia5 studier
- Illinois11 studier
- Indiana6 studier
- Iowa5 studier
- Kansas5 studier
- Louisiana3 studier
- Maryland6 studier
- Massachusetts13 studier
- Michigan9 studier
- Minnesota14 studier
- Missouri11 studier
- Nebraska4 studier
- Nevada5 studier
- New Jersey9 studier
- New York20 studier
- North Carolina12 studier
- Ohio12 studier
- Oklahoma4 studier
- Oregon6 studier
- Pennsylvania15 studier
- South Carolina6 studier
- South Dakota5 studier
- Tennessee13 studier
- Texas19 studier
- Utah5 studier
- Virginia13 studier
- Washington9 studier
- Wisconsin7 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05677490A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07090499Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06324357A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07221149Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07603375Lucid Registry Study
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05965999Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07392892A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07277413Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06005493Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07546812Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 50 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06687603A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07818018Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06732388Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Rekrutterer
Alder 18 til 89 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT05753748A Study of KK2269 in Adult Participants With Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06266299Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07431281Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT07282912A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 27. aug. 2026 · NCT07544589Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT07222657A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT07182149Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 14. aug. 2026 · NCT04221893Obeticholic Acid for Prevention in Barrett's Esophagus
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT04939051A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. aug. 2026 · NCT06330064A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 15. jul. 2026 · NCT06657144Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.